Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.

Launois C, Leu-Semenescu S, Brion A, Arnulf I.

Sleep Med. 2013 Jul;14(7):696. doi: 10.1016/j.sleep.2013.04.009. Epub 2013 May 25. No abstract available.

PMID:
23714418
2.

Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome.

Dorfman BJ, Nirenberg MJ.

Parkinsonism Relat Disord. 2013 Feb;19(2):269-70. doi: 10.1016/j.parkreldis.2012.06.006. Epub 2012 Jun 29. No abstract available.

PMID:
22749683
3.

[Impulse control disorder induced by the use of dopamine agonists].

Weber WE, Nijssen PC.

Ned Tijdschr Geneeskd. 2009 Jan 17;153(3):80-1. Dutch. No abstract available.

PMID:
19235343
4.

Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.

Bayard S, Langenier MC, Dauvilliers Y.

Sleep. 2013 Oct 1;36(10):1501-7. doi: 10.5665/sleep.3044.

5.

Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample.

Allen RP, Ondo WG, Ball E, Calloway MO, Manjunath R, Higbie RL, Lee MR, Nisbet PA.

Sleep Med. 2011 May;12(5):431-9. doi: 10.1016/j.sleep.2011.03.003. Epub 2011 Apr 13.

PMID:
21493132
6.

Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study.

Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH.

Sleep. 2010 Jan;33(1):81-7.

7.

The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndrome.

Dang D, Cunnington D, Swieca J.

Clin Neuropharmacol. 2011 Mar-Apr;34(2):66-70. doi: 10.1097/WNF.0b013e31820d6699.

PMID:
21412200
8.

Evaluation of painful sensory symptoms in restless legs syndrome: experience from two clinical trials.

Hornyak M, Sohr M, Busse M; 604 and 615 Study Groups.

Sleep Med. 2011 Feb;12(2):186-9. doi: 10.1016/j.sleep.2010.11.007. Epub 2011 Jan 21.

PMID:
21256799
9.

Recurrence of cluster headache with pramipexole.

Ossemann M.

Acta Neurol Belg. 2010 Sep;110(3):279-80.

PMID:
21114140
10.

Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.

Kolla BP, Mansukhani MP, Barraza R, Bostwick JM.

Psychosomatics. 2010 May-Jun;51(3):271-3. doi: 10.1176/appi.psy.51.3.271.

PMID:
20484726
11.

Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse.

Shimo Y, Nakajima A, Hattori N.

Neurol Sci. 2015 Jun;36(6):1021-3. doi: 10.1007/s10072-014-1996-x. Epub 2014 Nov 2. No abstract available.

PMID:
25362251
12.

Pramipexole (Mirapex) for restless legs syndrome.

[No authors listed]

Med Lett Drugs Ther. 2007 Mar 26;49(1257):26-8. No abstract available.

PMID:
17375031
13.

[Ropinirole treatment of restless legs].

Kinge E, Lossius MI, Mowincel P.

Ugeskr Laeger. 2005 Mar 14;167(11):1284-6. Danish. No abstract available.

PMID:
15830500
14.

Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists.

Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH.

Neurology. 2007 Jan 23;68(4):301-3.

PMID:
17242339
15.

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.

Trenkwalder C, Stiasny-Kolster K, Kupsch A, Oertel WH, Koester J, Reess J.

Mov Disord. 2006 Sep;21(9):1404-10.

PMID:
16755554
16.

Efficacy and safety of pramipexole in restless legs syndrome.

Kruszewski SP, Shane J.

Neurology. 2007 May 8;68(19):1641; author reply 1641-2. No abstract available.

PMID:
17485661
17.

Clinical experience with pramipexole in the treatment of restless legs syndrome.

Merlino G, Serafini A, Robiony F, Valente M, Gigli GL.

Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):225-35. doi: 10.1517/17425255.4.2.225. Review.

PMID:
18248314
18.

Pramipexole: new indication. Restless legs: still no satisfactory drug treatment.

[No authors listed]

Prescrire Int. 2007 Feb;16(87):12.

PMID:
17323517
19.

Ropinirole in restless leg syndrome.

Ahmed I.

Mo Med. 2002 Sep-Oct;99(9):500-1.

PMID:
12462942
20.

Ropinirole (Requip) for restless legs syndrome.

[No authors listed]

Med Lett Drugs Ther. 2005 Aug 1;47(1214):62-4. No abstract available.

PMID:
16052162
Items per page

Supplemental Content

Write to the Help Desk